Comparison of serum prostate-specific antigen levels and PSA density in African-American, white, and hispanic men without prostate cancer

Urology

Volumn 51, Issue 2, 1998, Pages 300-305

  Abdalla, Ibrahim ^a   Ray, Paul ^a   Ray, Vera ^a   Vaida, Florin ^a   Vijayakumar, Srinivasan ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ARTICLE; BLOOD LEVEL; CANCER SCREENING; CAUCASIAN; ETHNIC GROUP; HUMAN; MALE; NEGRO; NORMAL HUMAN; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RACE DIFFERENCE; RETROSPECTIVE STUDY; TRANSRECTAL ULTRASONOGRAPHY;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; EUROPEAN CONTINENTAL ANCESTRY GROUP; HISPANIC AMERICANS; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATE-SPECIFIC ANTIGEN;

EID: 0032006260     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(97)00617-1     Document Type: Article

References (39)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer Statistics, 1996. CA Can J Clin. 47:1997;5-27.
2. Muir C, Nectoux J, Staszewski J. The epidemiology of prostatic cancer. Acta Oncol. 30:1991;133-140.
3. Austin JP, Aziz H, Potters L, Thelmo W, Chen P, Choi K, Brandys M, Macchia RJ, Rotman M. Diminished survival of young blacks with adenocarcinoma of the prostate. Am J Clin Oncol. 13:1990;465-469.
4. Pienta KJ, Demers R, Hoff M, Kau TY, Montie JE, Severson RK. Effect of age and race on the survival of men with prostate cancer in the Metropolitan Detroit tricounty area 1973 to 1987. Urology. 45:1995;93-102.
5. Mebane C, Gibbs T, Horm J. Current status of prostate cancer in North American black males. J Natl Med Assoc. 82:1990;782-788.
6. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E. PSA as a serum marker for prostate adenocarcinoma. J Engl J Med. 317:1987;909-916.
7. Catatona WJ, Smith DS, Ratliff TL, Dodds KM, Coplen DE, Yuan JJ, Petros JA, Andriole GL. The measurement of PSA as a screening test for prostate cancer. N Engl J Med. 24:1991;1156-1161.
8. Brawer MK, Lange PH. PSA in the screening staging and follow-up of prostate cancer. World J Urol. 7:1989;7-11.
9. Brawer MK, Beatie J, Werner MH, Vessella RL, Preston SD, Lange PH. Screening for prostate carcinoma with PSA Results of the second year. J Urol. 150:1993;106-109.
10. Catalona WJ, Smith DS, Ratliff TL, Basler JW. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. J Am Med Assoc. 271:1993;192-193.
11. Mettlin C, Murphy GP, Lee F, Littrup PJ, Chesley A, Babaian R, Badalament R, Kane RA, Mostofi FK. Characteristics of prostate cancer detected in the American Cancer Society-National Prostate Cancer Detection Project. J Urol. 152:1994;1737-1740. (5 Pt 2).
12. Trapasso JG, deKernion JB, Smith RB, Dorey F. The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy. J Urol. 152:1994;1821-1825. (5 Pt 2).
13. Murphy G, Natarajan N, Pontes JE, Schmitz RL, Smart CR, Schmidt JD, Mettlin C. The national survey of prostate cancer in the United States by the American College of Surgeons. J Urol. 127:1982;928-934.
14. Morgan TO, Jacobsen SJ, McCarthy WF, Jacobson DJ, McLean DG, Moul JW. Age-specific reference ranges for serum prostate-specific antigen in black men. N Engl J Med. 335:1996;304-310.
15. Vijayakumar S, Karrison T, Weichselbaum RR, Chan S, Quadri SF, Awan AM. Racial differences in prostate-specific antigen levels in patients with local-regional prostate cancer. Cancer Epidemiol Biomark Prev. 1:1991;541-554.
16. Vijayakumar S, Weichselbaum R, Vaida F, Dale W, Hellman S. Prostate-specific antigen levels in African-Americans correlate with insurance status as an indicator of socio-economic status. Cancer J Sci Am. 2:1996;225-233.
17. Teshima T, Hanlon AM, Hanks GE. Pretreatment prostate-specific antigen values in patients with prostate cancer: 1989 patterns of care study process survey. Int J Radiat Oncol Biol Phys. 33:1995;809-814.
18. Moul JW, Sesterhenn IA, Connelly RR, Douglas T, Srivastava S, Mostofi FK, McLeod DG. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men. J Am Med Assoc. 274:1995;1277-1281.
19. Asbell SO, Vijayakumar S. Racial differences in prostate-specific antigen levels in patients with local-regional prostate cancer. Prostate. 31:1997;42-46.
20. Vijayakumar S, Winter K, Sause W, Gallagher MJ, Perez C, Bondy M. African-American (AA) men with local-regional prostate cancer (PC) present with higher prostate specific antigen (PSA) levels than whites: results of RTOG 94-12. Int J Radiat Oncol Biol Phys Suppl. 36:1996;305.
21. Whittemore A, Lele C, Friedman GD, Stamey T, Vogelman JH, aiOrentreich N. Prostate-specific antigen as predictor of prostate cancer in black men and white men. J Natl Cancer Inst. 87:1995;354-360.
22. Sakr WA, Haas GP, Cassin BF, Pontes JE, Crissman JD. The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol. 150:1993;379-385.
23. Sakr WA, Grignon DJ, Haas GP, Shomer KL, Heilburn LK, Cassin BJ, Powell J, Montie JA, Pontes JE, Crissman JD. Epidemiology of high grade prostatic intraepithelial neoplasia. Pathol Res Pract. 191:1995;838-841.
24. Brawer M, Rennels MA, Nagle RB, Schifman R, Gaines JA. Serum prostate-specific antigen and prostate pathology in men having simple prostatectomy. Am J Clin Pathol. 92:1989;760-764.
25. Cooner WH, Mosley BR, Rutherford CL Jr, Beard JH, Pond HS, Terry WJ, Igel TC, Kidd DD. Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. J Urol. 143:1990;1146-1152.
26. Ross R, Bernstein L, Judd H, Hanisch R, Pike M, Henderson B. Serum testosterone levels in healthy young black and white men. J Natl Cancer Inst. 76:1986;45-48.
27. Ross RK, Bernstein L, Lobo RA, Shimizu H, Stanczyk FZ, Pike MC, Henderson BF. 5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet. 339:1992;887-889.
28. Vijayakumar S, Quadri SF, Dong L, Ignacio L, Kathuria IN, Sutton H, Halpren H. Results of a study to correlate serum prostate specific antigen and reproductive hormone levels in patients with localized prostate cancer. J Natl Med Assoc. 87:1995;813-819.
29. Cooper CS, MacIndoe JH, Perry PJ, Yates WR, Williams RD. The effect of exogenous testosterone on total and free prostate specific antigen levels in healthy young men. J Urol. 156:1996;438-441.
30. Babaian RJ, Miyashita H, Evans RB, von Eschenbach AC, Ramirez EI. Early detection program for prostate cancer: results and identification of high-risk patient population. Urology. 37:1991;193-197.
31. Oesterling JE, Jacobsen SJ, Chute CG, Guess HA, Girman CJ, Panser LA, Lieber MM. Serum prostate-specific antigen in a community-based population of healthy men. J Am Med Assoc. 270:1993;860-864.
32. Speights VO Jr, Brawn PN, Foster DM, Spiekerman AM, Kuhl D, Riggs MW. Evaluation of age-specific normal ranges for prostate-specific antigen. Urology. 45:1995;454-457.
33. Mettlin C, Littrup PJ, Kane RA, Murphy GP, Lee F, Chesley A, Badalament R, Mostofi FK. Relative sensitivity and specificity of serum prostate specific antigen (PSA) level compared with age-referenced PSA, PSA density, and PSA change. Cancer. 74:1994;1615-1620.
34. Benson MC, Whang IS, Olsson CA, McMahon DJ, Cooner WH. The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J Urol. 147:1992;817-821. (3 Pt 2).
35. Benson MC, Whang IS, Pantuck A, Ring K, Kaplan SA, Olsson CA, Cooner WH. Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol. 147:1992;815-816. (3 Pt 2).
36. Albertsen PC. African-Americans and prostate cancer (commentary). Cancer J Sci Am. 2:1996;200-201.
37. Vijayakumar S, Winter K, Sause W, Gallagher MJ, Michalski J, Raoch M, Porter A, Bondy M: Prostate specific antigen levels are higher in African-American patients than whites in a multicenter registration study: results of RTOG 94-12. Int J Radiat Oncol Biol Phys (in press).
38. Vijayakumar S, Vaida F, Weichselbaum RR, Hellman S: Race and Will Rogers phenomenon in prostate cancer. Cancer J Sci Am (in press).
39. Dale W, Vijayakumar S, Lawlor EF, Merrell K. Prostate cancer, race, and socioeconomic status: inadequate adjustment for social factors in assessing racial differences. Prostate. 29:1996;271-281.